Fox Jennifer Lynne has filed 11 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 195876 shares of MYRIAD GENETICS INC ($MYGN) on March 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | MYRIAD GENETICS INC | $MYGN | Fox Jennifer Lynne | Chief Legal Officer | A | Common Stock | 195876 | $0.00 | 316,357.0000 | 93,213,722 | 162.58% | 0.21% |
| March 13, 2026 | MYRIAD GENETICS INC | $MYGN | Fox Jennifer Lynne | Chief Legal Officer | F | Common Stock | 5995 | $4.66 | 310,362.0000 | 93,213,722 | 1.90% | 0.01% |
| Sept. 3, 2025 | MYRIAD GENETICS INC | $MYGN | Fox Jennifer Lynne | Chief Legal Officer | F | Common Stock | 4435 | $6.80 | 120,481.0000 | 91,309,064 | 3.55% | 0.00% |
| March 13, 2025 | MYRIAD GENETICS INC | $MYGN | Fox Jennifer Lynne | Chief Legal Officer | A | Common Stock | 63145 | $0.00 | 124,916.0000 | 91,309,064 | 102.22% | 0.07% |
| Sept. 3, 2024 | MYRIAD GENETICS INC | $MYGN | Fox Jennifer Lynne | Chief Legal Officer | A | Common Stock | 61771 | $0.00 | 61,771.0000 | 0 | 9999.99% | 0.00% |
| July 11, 2024 | Emergent BioSolutions Inc. | $EBS | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | A | Common Stock | 15000 | $0.00 | 186,382.0000 | 51,200,000 | 8.75% | 0.03% |
| June 8, 2024 | Emergent BioSolutions Inc. | $EBS | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 2376 | $6.19 | 171,382.0000 | 51,200,000 | 1.37% | 0.00% |
| March 13, 2024 | Emergent BioSolutions Inc. | $EBS | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | A | Employee Stock Options (Right to Buy) | 125000 | $0.00 | 223,169.0000 | 51,200,000 | 127.33% | 0.24% |
| March 1, 2024 | Emergent BioSolutions Inc. | $EBS | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 703 | $3.39 | 173,758.0000 | 51,200,000 | 0.40% | 0.00% |
| Feb. 29, 2024 | Emergent BioSolutions Inc. | $EBS | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 4103 | $3.23 | 174,461.0000 | 51,200,000 | 2.30% | 0.01% |
| Feb. 23, 2024 | Emergent BioSolutions Inc. | $EBS | Fox Jennifer Lynne | EVP, Ext Aff, GC, Corp Sec | F | Common Stock | 229 | $2.74 | 178,564.0000 | 51,200,000 | 0.13% | 0.00% |